BlueDot
Jennifer holds a Master's degree in epidemiology and manages BlueDot’s international clients and partners, including the US Centers for Disease Control (CDC). Prior to BlueDot, she worked on the BioDiaspora academic research program at St. Michael's Hospital for six years coordinating research activities for government and academic stakeholders and before that spent 10 years in the private sector specializing in technology and license management.
BlueDot
2 followers
Toronto-based digital health firm BlueDot, has developed a first-of-its-kind, global early warning technology for infectious diseases. Using artificial and human intelligence, BlueDot’s outbreak risk platform tracks over 150 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. They empower national and international health agencies, hospitals, and businesses to better anticipate, and respond to, emerging threats. BlueDot was among the first in the world to identify the emerging risk from, and publish a scientific paper on, COVID-19, and delivers regular critical Insights to its partners and customers worldwide to mobilize timely, effective, efficient, coordinated, and measured responses.